Secondary Sjögren’s Syndrome in Rheumatological Patients

It is not uncommon for patients with rheumatological disease to develop secondary Sjögren’s syndrome, which is also known as keratoconjunctivitis sicca. This condition is characterized by a reduction in secretions, particularly in the salivary and lacrimal glands. One of the diagnostic tests used to identify this condition is the Schirmer’s test. This test is a simple procedure that measures the production of tears in the eyes. During the test, a strip of paper is placed under the eyelid of the patient, and after five minutes, the amount of moistness on the paper is measured. If the moistness is less than 5 mm, it is suggestive of Sjögren’s syndrome.

Overall, secondary Sjögren’s syndrome is a common condition that can occur in patients with rheumatological disease. The Schirmer’s test is a simple and effective way to diagnose this condition, and it can help healthcare professionals provide appropriate treatment to patients.

Juvenile Idiopathic Arthritis (JIA) and its Characteristics

Juvenile Idiopathic Arthritis (JIA) is a condition characterized by persistent joint swelling in children under 16 years of age without any known cause. It is not the same as rheumatoid arthritis, as only 5% of JIA cases are rheumatoid factor positive polyarthritis. Instead, 60% of JIA cases are ANA+ oligoarthritis. Children with JIA may also experience systemic symptoms, such as chronic anterior uveitis, which requires regular screening. Chronic inflammation can lead to secondary amyloidosis, while poor growth, anorexia, and anaemia are common due to chronic disease and steroid therapy.

Overall, JIA is a complex condition that can have a significant impact on a child’s health and wellbeing. It is important for healthcare professionals to be aware of the various characteristics of JIA and to provide appropriate care and support to affected children and their families.

Joint Pain in Children and Hypermobility Syndrome

Joint pain in children can have various causes, including hypermobility syndrome. This condition is characterized by increased flexibility, as opposed to hereditary connective tissue disorders. The Beighton score is a method used to assess hypermobility, which involves ten tests. A score of 9 indicates high flexibility and suggests susceptibility to hypermobility syndrome. Although there is no intrinsic joint disease or clinical synovitis, joint pain can be experienced. Physiotherapy can help strengthen the soft tissues supporting joints and reduce pain.

In mild juvenile idiopathic arthritis (JIA), which may present similarly to hypermobility syndrome, ibuprofen is the first line of management. However, if joints show clinical synovitis, methotrexate may be considered for severe JIA. It is important to reassure the child and parents that the pain is not sinister, but it is not the optimal management for this condition. Genetic conditions causing hypermobility, such as Ehlers-Danlos and Marfan syndrome, may require referral for genetic counseling, but there are no other features of these syndromes present in hypermobility syndrome.